“[The conference] brings exactly what I’m looking for—pharma executives, biotechs bringing innovation and looking for partnerships, and a great group of investors.”
Detlev Mennerich, Ph.D.
Global Head, Boehringer Ingelheim Venture Fund
“A very target-rich environment of pharma people in addition to venture capitalists and young companies.”
Camille Samuels
Director, Venrock Boards
“I’ve been attending the conference for quite a few years and each year continues to get better and better.”
Richard Heyman, Ph.D.
Venture Partner, ARCH Ventures
